Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD19 Universal CAR-γδT Cells in Active SLE
NCT06106893Phase 2Recruiting
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD19 Universal CAR-γδ T Cells in systemic lupus erythematosus (SLE). Started Jan 2024; status: recruiting.
02
Drugs
CD19 Universal CAR-γδ T Cells
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT06106893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06106893.